Mukozite Yönelik Kanıta Dayalı Uygulamalar

Mukozit, oral ve/veya gastrointestinal sistemin enfl amatuvar ve/veya ülserli lezyonları olarak tanımlanmaktadır. Hastanede yatış süresini, enfeksiyon riskini, total parenteral beslenme ve opioid analjezik kullanım gereksinimini artırır ve hastanın yaşam kalitesini olumsuz etkiler. Mukozitin önlenmesi ve tedavisi için geliştirilen kanıta dayalı rehberlerin klinik alanda kullanımı son derece önemlidir. Hemşireler mukozit yönetiminde kanıta dayalı klinik uygulama rehberlerini uygulama ve değerlendirmede önemli role sahiptirler.

Evidence-Based Practices for Mucositis

Mucositis is the infl ammation and ulceration of the mucous membranes in the oral and/or gastrointestinal tracts. Mucositis can increase the length of hospital stays, the risk of infection, and the need for total parenteral nutrition and opioid analgesics, which can all affect a patient's quality of life negatively. The use of evidence-based guidelines developed for prevention and treatment of mucositis is extremely important in clinical areas. Nurses play a signiŞ cant role in implementing and evaluating evidence-based practice guidelines for managing mucositis.

PDF

___

1 . Worthington HV, Clarkson JE, Bryan G, et al. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev. 2011; 13(4):1-27. doi:10.1002/14651858. CD000978.pub5
2 . Peterson DE, Bensadoun RJ, Roila F. Management of oral and gastrointestinal mucositis: ESMO Clinical Recommendations. Ann Oncol. 2011;22(6):7884. doi:10.1093/annonc/mdr391
3 . Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Support Care Cancer. 2000; 8(1):33-39. https://www.ncbi.nlm.nih.gov/pubmed/10650895
4 . Saadeh CE. Chemotherapy- and radiotherapy-induced oral mucositis: review of preventive strategies and treatment. Pharmacotherapy. 2005; 25(4):540-554. https://www.ncbi.nlm.nih.gov/pubmed/15977916
5 . Sonis ST, Peterson DE, McGuire DB, Williams DA. Prevention of mucositis in cancer patients. J Natl Cancer Inst Monogr. 2001; (29):1-2. https://www.ncbi.nlm.nih.gov/pubmed/11694556
6 . Eılers J, Mıllıon R. Prevention and Management of Oral Mucositis In Patıents with Cancer. Semin Oncol Nurs. 2007; 23(3):201-212. http:// dx.doi.org/10.1016/j.soncn.2007.05.005
7 . Popescu RA, Norman A, Ross PJ, Parikh B, Cunningham D. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol. 1999; 17(8):2412-2418. https://www.ncbi.nlm. nih.gov/pubmed/10561304
8 . Meta-Analysis Group in Cancer. Toxicity of fl uorouracil in patients with advanced colorectal cancer: effect of administration administration schedule and prognostic factors. Meta-Analysis Group in Cancer. J Clin Oncol. 1998; 16(11):3537-3541. https://www.ncbi.nlm.nih.gov/ pubmed/9817272
9 . Trotti A, Byhardt R, Stetz J, et al. Common Toxicity Criteria: Version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys. 2000; 47(1):13-47. https://www.ncbi.nlm.nih.gov/pubmed/10758303
10 . Keefe DMK. Mucositis guidelines: what have they achieved, and where to from here? Support Care Cancer, 2006; 14(6):489-491. https://www. ncbi.nlm.nih.gov/pubmed/16572311
11 . Keefe DM, Schubert MM, Elting LS, et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer, 2007; 109(5): 820-831. doi:10.1002/cncr.22484
12 . Somerfi eld MR, Einhaus K, Hagerty KL, et al. American Society of Clinical Oncology practice guidelines: opprtunities and challenges. J Clin Oncol. 2008; 24(20):4022-4026. doi:10.1200/JCO.2008.17.7139
13 . Can G. Onkoloji hemşireliğinde kanıta dayalı semptom yönetimi. 3P Pharma Publication Planning Mavi İletişim Danışmanlık A.Ş, İstanbul; 2007.
14 . Stone R, Fliedner MC, Smiet AC. Management of oral mucositis in patients with cancer. Eur J Oncol Nurs. 2005; 9(1):24-32. doi:10.1016/ j.ejon.2005.08.004
15 . Yılmaz MÇ. Evidence-based practices for managing mucositis. UHOD. 2007; 26(4):241-246. http://www.uhod.org/pdf/PDF_303.pdf
16 . Rubenstein EB, Peterson DE, Schubert M, et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer, 2004; 100(9):2026-2046. doi:10.1002/cncr.20163
17 . McGuire DB, Correa MEP, Johson J, Wienandts P. The role of the basic oral care and good clinical practice principles in the management of oral mucositis. Support Care Cancer, 2006; 14:541-547. doi:10.1007/ s00520-006-0051-8
18 . Stricker CT. Evidenced based oncology oral care clinical practice guidelines: development, implementation and evaluation. Clin J Oncol Nurs. 2003; 7(2):222-227. https://www.ncbi.nlm.nih.gov/ pubmed/12696221
19 . Lalla RV, Bowen J, Barasch A, et al. MASCC=ISOO Clinical Practice Guidelines for the Management of Mucositis Secondary to Cancer Therapy. Cancer, 2014; 120(10):1453-1461. doi:10.1002/cncr.28592
20 . Lilleby K, Garcia P, Gooley T, et al. A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 2006; 37(11):1031-1035. doi:10.1038/sj.bmt.1705384
21 . Gori E, Arpinati M, Bonifazi F, et al. Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplant. 2007; 39(6):347-352. doi:10.1038/sj.bmt.1705590
22 . Rosen LS, Abdi E, Davis ID, Gutheil J, Schnell FM, Zalcberg J, et al. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy. J Clin Oncol. 2006; 24(33):5194-200. doi:10.1200/ JCO.2005.04.1152
23 . Spielberger R, Stiff P, Bensinger W, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med. 2004; 351(25):2590-2598. doi:10.1056/NEJMoa040125
24 . Kazemian A, Kamian S, Aghili M, Hashemi FA, Haddad P. Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebocontrolled randomized clinical trial. Eur J Cancer Care. 2009; 18(2):174-178. doi:10.1111/j.1365-2354.2008.00943.x
25 . Miller M, Kearney N. Oral care for patients with cancer: a review of the literature. Cancer Nurs. 2001; 24(4):241-254. https://www.ncbi.nlm. nih.gov/pubmed/11502032
26 . Spencer A, Horvath N, Gibson J, et al. Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation. Bone Marrow Transplant. 2005; 35(10):971-977. doi:10.1038/sj.bmt.1704946
27 . Hartmann J, von Vangerow A, Knop S, et al. A randomized trial comparing the toxicity and the treatment costs of HD-VIC plus PBSC transplantation with or without amifostine (AMI) in patients with solid tumors. Eur J Cancer. 1999; 35(4):361. doi:10.1016/S0959- 8049(99)81879-6
28 . Cengiz M, Ozyar E, Öztürk D, Akyol F, Atahan IL, Hayran M. Sucralfate in the prevention of radiation-induced oral mucositis. J Clin Gastroenterol. 1999; 28(1):40-43. https://www.ncbi.nlm.nih.gov/ pubmed/9916664
29 . Nottage M, McLachlan SA, Brittain MA, et al. Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: a randomized, placebo-controlled trial. Supportive Care Cancer, 2003; 11(1):41-47. doi:10.1007/s00520-002-0378-8
30 . Kokkonen J, Karttunen TJ, Lanning M. Mucosal pathology of the upper gastrointestinal tract associated with intensive chemotherapy in children: vitamin A supplements do not prevent lesions. Paediatr H e a m a t o l O n c o l . 2 0 0 2 ; 1 9 ( 3 ) : 1 8 1 - 1 9 2 . doi:10.1080/088800102753541332
31 . Jahangard-Rafsanjani Z, Gholami K, Hadjibabaie M, et al. The effi cacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial. Bone Marrow Transplant. 2013; 48(6):832-836. doi:10.1038/bmt.2012.250
32 . Panahi Y, Ala S, Saeedi M, Okhovatian A, Bazzaz N, Naghizadeh MM. Allopurinol mouth rinse for prophylaxis of fluorouracil-induced mucositis. Eur J Cancer Care. 2010; 19(3):308-312. doi:10.1111/j.1365-2354.2008.01042.x
33 . Puataweepong P, Dhanachai M, Dangprasert S, et al. The effi cacy of oral aloe vera for radiation induced mucositis in head and neck cancer patients: a double-blind placebo controlled study. Asian Biomed. 2009; 3(4):375-382. http://imsear.li.mahidol.ac.th/ bitstream/123456789/129903/1/abm2009v3n4p375.pdf
34 . Khanal B, Baliga M, Uppal N. Effect of topical honey on limitation of radiation-induced oral mucositis: an intervention study. Int J Oral Maxillofac Surg. 2010; 39(12):1181-1185. doi:10.1016/j. ijom.2010.05.014
35 . Benderli Cihan Y, Deniz K. Sıçanlarda radyasyona bağlı oral mukozitte propolisin etkisi. Kulak Burun Boğaz İhtis Derg. 2011; 21(1):32-41. http://www.kbbihtisas.org/v02/jvi.php?pdir=kbbihtisas&plng=tur&un =KBBI-69188&look4=
36 . Benderli Cihan Y, Deniz K. The Effects of Royal Jelly Against RadiationInduced Acute Oral Mucositis. UHOD, 2014; 1(24):36-44. http://www. uhod.org/pdf/PDF_596.pdf
37 . Topuz E, Derin D, Can G, et al. Effect of oral administration of kefi r on serum proinfl ammatory cytokines on 5-FU induced oral mucositis in patients with colorectal cancer. Invest New Drugs. 2008; 26(6):567- 572. doi:10.1007/s10637-008-9171-y
38 . Mazokopakis EE, Vrentzos GE, Papadakis JA, Babalis DE, Ganotakis ES. Wild chamomile (matricaria recutita l.) mouthwashes in methotrexateinduced oral mucositis. Phytomedicine, 2005; 12(1-2): 25-27. doi:10.1016/j.phymed.2003.11.003
39 . Fidler P, Loprinzi CL, O'Fallon JR, et al. Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis. Cancer, 1996; 77(3):522-525. doi:10.1002/(SICI)1097- 0142(19960201)77:3_____522::AID-CNCR14>3.0.CO;2-6
40 . Mutluay Yayla E, İzgü N, Özdemir L, Aslan Erdem S, Kartal M. Sage tea-thyme-peppermint hydrosol oral rinse reduces chemotherapyinduced oral mucositis: a randomized controlled pilot study. Complement Ther Med. 2016; 27; 58-64. d o i : 1 0 . 1 0 1 6 / j . ctim.2016.05.010
41 . Çubukçu NÜ, Çınar S. Kemoterapi Alan Kanserli Hastalarda Oral Mukozitler Önlenebilir mi? MÜSBED, 2012; 2(4):155-163. http://e-dergi.marmara.edu.tr/marusbed/article/ view/5000003676/5000004190